data_5508

#N.B. (Observed* = Observed shift + Offset correction)
#
#After reference correction, the following residues still 
#have a CA chemical shift difference (obs*-pred) greater than  5.0ppm:
#NUM  AA    CS     Observed*    Predicted
# 11   C    CA      50.93        59.09
# 90   E    CA      53.38        59.67
#
#After reference correction, the following residues still 
#have a N chemical shift difference (obs*-pred) greater than 10.0ppm:
#NUM  AA    CS     Observed*    Predicted
#105   R    N      106.08       118.38
#
#The average CS difference between predicted and observed:
#HA       CA       CB      CO       N      HN
#N/A     0.39      N/A     N/A   0.08    0.04    
#
#R098_bmr5508.str.corr chemical shifts have been re-referenced with the following 
#offsets (these values have been added to the original R098_bmr5508.str file):
#HA       CA       CB      CO       N      HN
#N/A   +0.39      N/A     N/A   +0.08     N/A
#
#The 95% confidence intervals for the above recommended offsets are:
#    HA       CA       CB       CO       N        HN
#    N/A  +/-0.15      N/A      N/A  +/-0.29  +/-0.05  
#
#The Correlation Coefficients between predicted and observed 
#chemical shifts are:
#HA       CA       CB      CO       N      HN
#N/A     0.947     N/A     N/A   0.903   0.771   
#
#The RMSD between predicted and observed* (reference 
#corrected) chemical shifts are:
#HA       CA       CB      CO       N       HN
#N/A     0.773     N/A     N/A   1.472   0.247   
#



#######################
#  Entry information  #
#######################

save_entry_information
   _Saveframe_category      entry_information

   _Entry_title            
;
Native State Hydrogen Exchange Study of Suppressor and Pathogenic Variants of 
Transthyretin
;

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

      1 Liu    Kai     . . 
      2 Kelly  Jeffery . . 
      3 Wemmer David   . . 

   stop_

   _BMRB_accession_number   5508
   _BMRB_flat_file_name     bmr5508.str
   _Entry_type              new
   _Submission_date         2002-08-25
   _Accession_date          2002-08-26
   _Entry_origination       author
   _NMR_STAR_version        2.1.1
   _Experimental_method     NMR

   loop_
      _Saveframe_category_type
      _Saveframe_category_type_count

      assigned_chemical_shifts 1 

   stop_

   loop_
      _Data_type
      _Data_type_count

      '1H chemical shifts'  121 
      '15N chemical shifts' 121 
      '13C chemical shifts' 128 

   stop_

   loop_
      _Related_BMRB_accession_number
      _Relationship

      5507 "wild type transthyretin" 
      5509 "mutant v30m"             
      5510 "mutant l55p"             

   stop_

save_


#############################
#  Citation for this entry  #
#############################

save_entry_citation
   _Saveframe_category     entry_citation

   _Citation_title        
;
Native State Hydrogen Exchange Study of Suppressor and Pathogenic Variants of 
Transthyretin
;
   _Citation_status        published
   _Citation_type          journal
   _MEDLINE_UI_code        22090787
   _PubMed_ID              12095258

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

      1 Liu    Kai     . . 
      2 Kelly  Jeffery . . 
      3 Wemmer David   . . 

   stop_

   _Journal_abbreviation  'J. Mol. Biol.'
   _Journal_volume         320
   _Journal_issue          4
   _Page_first             821
   _Page_last              832
   _Year                   2002

   loop_
      _Keyword

      "transthyretin"     
      "amyloid"           
      "hydrogen exchange" 
      "NMR spectroscopy"  
      "protection factor" 

   stop_

save_


##################################
#  Molecular system description  #
##################################

save_system_TTR
   _Saveframe_category         molecular_system

   _Mol_system_name            Transthyretin
   _Abbreviation_common        TTR
   _Enzyme_commission_number   .

   loop_
      _Mol_system_component_name
      _Mol_label

      "TTR subunit 1" $TTR_T119M 
      "TTR subunit 2" $TTR_T119M 
      "TTR subunit 3" $TTR_T119M 
      "TTR subunit 4" $TTR_T119M 

   stop_

   _System_physical_state      native
   _System_oligomer_state      tetramer
   _System_paramagnetic        no
   _System_thiol_state        "all free"

   loop_
      _Magnetic_equivalence_ID
      _Magnetically_equivalent_system_component

      1 "TTR subunit 1" 
      1 "TTR subunit 2" 
      1 "TTR subunit 3" 
      1 "TTR subunit 4" 

   stop_

   loop_
      _Database_name
      _Database_accession_code
      _Database_entry_mol_name
      _Database_entry_details

      PDB 1F41 . . 
      PDB 1F86 . . 

   stop_

save_


    ########################
    #  Monomeric polymers  #
    ########################

save_TTR_T119M
   _Saveframe_category                          monomeric_polymer

   _Mol_type                                    polymer
   _Mol_polymer_class                           protein
   _Name_common                                 Transthyretin
   _Name_variant                                T119M
   _Abbreviation_common                         TTR
   _Mol_thiol_state                            "all free"
   
   	##############################
   	#  Polymer residue sequence  #
   	##############################
   
   _Residue_count                               128
   _Mol_residue_sequence                       
;
MGPTGTGESKCPLMVKVLDA
VRGSPAINVAVHVFRKAADD
TWEPFASGKTSESGELHGLT
TEEEFVEGIYKVEIDTKSYW
KALGISPFHEHAEVVFTAND
SGPRRYTIAALLSPYSYSTM
AVVTNPKE
;

   loop_
      _Residue_seq_code
      _Residue_label

        1 MET    2 GLY    3 PRO    4 THR    5 GLY 
        6 THR    7 GLY    8 GLU    9 SER   10 LYS 
       11 CYS   12 PRO   13 LEU   14 MET   15 VAL 
       16 LYS   17 VAL   18 LEU   19 ASP   20 ALA 
       21 VAL   22 ARG   23 GLY   24 SER   25 PRO 
       26 ALA   27 ILE   28 ASN   29 VAL   30 ALA 
       31 VAL   32 HIS   33 VAL   34 PHE   35 ARG 
       36 LYS   37 ALA   38 ALA   39 ASP   40 ASP 
       41 THR   42 TRP   43 GLU   44 PRO   45 PHE 
       46 ALA   47 SER   48 GLY   49 LYS   50 THR 
       51 SER   52 GLU   53 SER   54 GLY   55 GLU 
       56 LEU   57 HIS   58 GLY   59 LEU   60 THR 
       61 THR   62 GLU   63 GLU   64 GLU   65 PHE 
       66 VAL   67 GLU   68 GLY   69 ILE   70 TYR 
       71 LYS   72 VAL   73 GLU   74 ILE   75 ASP 
       76 THR   77 LYS   78 SER   79 TYR   80 TRP 
       81 LYS   82 ALA   83 LEU   84 GLY   85 ILE 
       86 SER   87 PRO   88 PHE   89 HIS   90 GLU 
       91 HIS   92 ALA   93 GLU   94 VAL   95 VAL 
       96 PHE   97 THR   98 ALA   99 ASN  100 ASP 
      101 SER  102 GLY  103 PRO  104 ARG  105 ARG 
      106 TYR  107 THR  108 ILE  109 ALA  110 ALA 
      111 LEU  112 LEU  113 SER  114 PRO  115 TYR 
      116 SER  117 TYR  118 SER  119 THR  120 MET 
      121 ALA  122 VAL  123 VAL  124 THR  125 ASN 
      126 PRO  127 LYS  128 GLU 

   stop_

   _Sequence_homology_query_date                2010-05-15
   _Sequence_homology_query_revised_last_date   2010-05-15

   loop_
      _Database_name
      _Database_accession_code
      _Database_entry_mol_name
      _Sequence_query_to_submitted_percentage
      _Sequence_subject_length
      _Sequence_identity
      _Sequence_positive
      _Sequence_homology_expectation_value

      BMRB      2476 "pancreatic polypeptide"                                                                                                                                   99.22 127  99.21  99.21 1.26e-67 
      BMRB      5507  Transthyretin                                                                                                                                            100.00 128  99.22  99.22 1.87e-68 
      BMRB      5509  Transthyretin                                                                                                                                            100.00 128  98.44  99.22 4.80e-68 
      BMRB      5510  Transthyretin                                                                                                                                            100.00 128  98.44  98.44 2.14e-67 
      PDB  1BM7       "Human Transthyretin (Prealbumin) Complex With Flufenamic Acid (2-[[3-(Trifluoromethyl)phenyl]amino] Benzoic Acid)"                                        99.22 127  99.21  99.21 1.26e-67 
      PDB  1BMZ       "Human Transthyretin (Prealbumin)"                                                                                                                         99.22 127  99.21  99.21 1.26e-67 
      PDB  1BZ8       "Transthyretin (Del Val122)"                                                                                                                               99.22 126  98.43  98.43 9.92e-66 
      PDB  1BZD       "Tertiary Structures Of Three Amyloidogenic Transthyretin Variants And Implications For Amyloid Fibril Formation"                                          99.22 127  98.43  98.43 5.00e-67 
      PDB  1BZE       "Tertiary Structures Of Three Amyloidogenic Transthyretin Variants And Implications For Amyloid Fibril Formation"                                          99.22 127 100.00 100.00 2.21e-68 
      PDB  1DVQ       "Crystal Structure Of Human Transthyretin"                                                                                                                 96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVS       "Crystal Structure Of Human Transthyretin In Complex With Resveratrol"                                                                                     96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVT       "Crystal Structure Of Human Transthyretin In Complex With Flurbiprofen"                                                                                    96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVU       "Crystal Structure Of Human Transthyretin In Complex With Dibenzofuran-4,6-Dicarboxylic Acid"                                                              96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVX       "Crystal Structure Of Human Transthyretin In Complex With Diclofenac"                                                                                      96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVY       "Crystal Structure Of Transthyretin In Complex With N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid"                                        96.88 124  98.39  99.19 1.28e-65 
      PDB  1DVZ       "Crystal Structure Of Human Transthyretin In Complex With O- Trifluoromethylphenyl Anthranilic Acid"                                                       96.88 124  98.39  99.19 1.28e-65 
      PDB  1E3F       "Structure Of Human Transthyretin Complexed With Bromophenols: A New Mode Of Binding"                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  1E4H       "Structure Of Human Transthyretin Complexed With Bromophenols: A New Mode Of Binding"                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  1E5A       "Structure Of Human Transthyretin Complexed With Bromophenols: A New Mode Of Binding"                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  1ETA       "The X-Ray Crystal Structure Refinements Of Normal Human Transthyretin And The Amyloidogenic Val 30-->met Variant To 1.7 Angstroms Resolution"            100.00 128  98.44  98.44 2.42e-66 
      PDB  1ETB       "The X-Ray Crystal Structure Refinements Of Normal Human Transthyretin And The Amyloidogenic Val 30-->met Variant To 1.7 Angstroms Resolution"             99.22 127  98.43  98.43 3.99e-67 
      PDB  1F41       "Crystal Structure Of Human Transthyretin At 1.5a Resolution"                                                                                              99.22 127  99.21  99.21 1.26e-67 
      PDB  1F86       "Transthyretin Thr119met Protein Stabilisation"                                                                                                            89.84 115 100.00 100.00 2.55e-61 
      PDB  1FH2       "Transthyretin Stability As A Key Factor In Amyloidogenesis"                                                                                               90.63 116  98.28  98.28 6.72e-58 
      PDB  1FHN       "Transthyretin Stability As A Key Factor In Amyloidogenesis"                                                                                               99.22 127 100.00 100.00 2.21e-68 
      PDB  1ICT       "Monoclinic Form Of Human Transthyretin Complexed With Thyroxine (T4)"                                                                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  1III       "Crystal Structure Of The Transthyretin Mutant Ttr Y114c- Data Collected At Room Temperature"                                                              99.22 127  98.43  98.43 1.32e-66 
      PDB  1IIK       "Crystal Structure Of The Transthyretin Mutant Ttr Y114c- Data Collected At Cryo Temperature"                                                              99.22 127  98.43  98.43 1.32e-66 
      PDB  1QAB       "The Structure Of Human Retinol Binding Protein With Its Carrier Protein Transthyretin Reveals Interaction With The Carboxy Terminus Of Rbp"               99.22 127  98.43  99.21 1.85e-67 
      PDB  1QWH       "A Covalent Dimer Of Transthyretin That Affects The Amyloid Pathway"                                                                                       91.41 117  99.15  99.15 3.77e-61 
      PDB  1RLB       "Retinol Binding Protein Complexed With Transthyretin"                                                                                                     99.22 127  98.43  99.21 1.85e-67 
      PDB  1THA       "Mechanism Of Molecular Recognition. Structural Aspects Of 3, 3'-Diiodo-L-Thyronine Binding To Human Serum Transthyretin"                                  99.22 127  98.43  99.21 1.85e-67 
      PDB  1THC       "Crystal Structure Determination At 2.3a Of Human Transthyretin-3',5'-Dibromo-2',4,4',6-Tetra-Hydroxyaurone Complex"                                       99.22 127  98.43  99.21 1.85e-67 
      PDB  1TLM       "Structural Aspects Of Inotropic Bipyridine Binding: Crystal Structure Determination To 1.9 Angstroms Of The Human Serum Transthyretin-Milrinone Complex"  99.22 127  98.43  99.21 1.85e-67 
      PDB  1TSH       "Tertiary Structures Of Three Amyloidogenic Transthyretin Variants And Implications For Amyloid Fibril Formation"                                          99.22 127  98.43  98.43 4.53e-67 
      PDB  1TT6       "The Orthorhombic Crystal Structure Of Transthyretin In Complex With Diethylstilbestrol"                                                                   99.22 127  99.21  99.21 1.26e-67 
      PDB  1TTA       "The X-Ray Crystal Structure Refinements Of Normal Human Transthyretin And The Amyloidogenic Val30met Variant To 1.7 Angstroms Resolution"                 99.22 127  99.21  99.21 1.26e-67 
      PDB  1TTB       "The X-Ray Crystal Structure Refinements Of Normal Human Transthyretin And The Amyloidogenic Val30met Variant To 1.7 Angstroms Resolution"                 99.22 127  98.43  98.43 3.99e-67 
      PDB  1TTC       "The X-Ray Crystal Structure Refinements Of Normal Human Transthyretin And The Amyloidogenic Val30met Variant To 1.7 Angstroms Resolution"                 99.22 127  98.43  99.21 2.55e-67 
      PDB  1TTR       "Transthyretin-V122I CARDIOMYOPATHIC MUTANT"                                                                                                               99.22 127  98.43  99.21 1.60e-67 
      PDB  1TYR       "Transthyretin Complex With Retinoic Acid"                                                                                                                 99.22 127  99.21  99.21 1.26e-67 
      PDB  1TZ8       "The Monoclinic Crystal Struture Of Transthyretin In Complex With Diethylstilbestrol"                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  1U21       "Transthyretin With Tethered Inhibitor On One Monomer."                                                                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  1X7S       "The X-Ray Crystallographic Structure Of The Amyloidogenic Variant Ttr Tyr78phe"                                                                           99.22 127  98.43  99.21 3.27e-67 
      PDB  1X7T       "Structure Of Ttr R104h: A Non-Amyloidogenic Variant With Protective Clinical Effects"                                                                     99.22 127  98.43  98.43 8.53e-67 
      PDB  1Y1D       "Crystal Structure Of Transthyretin In Complex With Iododiflunisal"                                                                                        99.22 127  99.21  99.21 1.26e-67 
      PDB  1Z7J       "Human Transthyretin (Also Called Prealbumin) Complex With 3, 3',5,5'-Tetraiodothyroacetic Acid (T4ac)"                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  1ZCR       "Crystal Structure Of Human Transthyretin With Bound Iodide"                                                                                              100.00 128  99.22  99.22 1.87e-68 
      PDB  1ZD6       "Crystal Structure Of Human Transthyretin With Bound Chloride"                                                                                            100.00 128  99.22  99.22 1.87e-68 
      PDB  2B14       "The Crystal Structure Of 2,4-Dinitrophenol In Complex With The Amyloidogenic Variant Transthyretin Leu 55 Pro"                                            99.22 127  98.43  98.43 1.40e-66 
      PDB  2B15       "The Crystal Structure Of 2,4-Dinitrophenol In Complex With Human Transthyretin"                                                                           99.22 127  99.21  99.21 1.26e-67 
      PDB  2B16       "The Crystal Structure Of 2,4-Dinitrophenol In Complex With The Amyloidogenic Variant Transthyretin Tyr78phe"                                              99.22 127  98.43  99.21 3.27e-67 
      PDB  2B77       "Human Transthyretin (Ttr) Complexed With Diflunisal Analogues- Ttr.2',4'-Dichloro-4-Hydroxy-1,1'-Biphenyl-3- Carboxylic Acid"                             99.22 127  99.21  99.21 1.26e-67 
      PDB  2B9A       "Human Transthyretin (Ttr) Complexed With Diflunisal Analogues- Ttr.3',5'-Difluorobiphenyl-4-Carboxylic Acid"                                              99.22 127  99.21  99.21 1.26e-67 
      PDB  2F7I       "Human Transthyretin (Ttr) Complexed With Diflunisal Analogues- Ttr. 2',6'-Difluorobiphenyl-4-Carboxylic Acid"                                             99.22 127  99.21  99.21 1.26e-67 
      PDB  2F8I       "Human Transthyretin (Ttr) Complexed With Benzoxazole"                                                                                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  2FBR       "Human Transthyretin (Ttr) Complexed With Bivalant Amyloid Inhibitor (4 Carbon Linker)"                                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  2FLM       "Human Transthyretin (Ttr) Complexed With Bivalant Amyloid Inhibitor (6 Carbon Linker)"                                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  2G3X       "Crystal Structure Of Transthyretin Mutant I84s At Acidic Ph"                                                                                              99.22 127  98.43  98.43 7.16e-67 
      PDB  2G3Z       "Crystal Structure Of Transthyretin Mutant I84a At Low Ph"                                                                                                 99.22 127  98.43  98.43 5.39e-67 
      PDB  2G4E       "Crystal Structure Of Transthyretin Mutant I84a At Neutral Ph"                                                                                             99.22 127  98.43  98.43 5.39e-67 
      PDB  2G4G       "Crystal Structure Of Human Transthyretin At Ph 4.6"                                                                                                       99.22 127  99.21  99.21 1.26e-67 
      PDB  2G5U       "Human Transthyretin (Ttr) Complexed With Hydroxylated Polychlorinated Biphenyl-4,4'-Dihydroxy-3,3',5,5'- Tetrachlorobiphenyl"                             99.22 127  99.21  99.21 1.26e-67 
      PDB  2G9K       "Human Transthyretin (Ttr) Complexed With Hydroxylated Polychlorinated Biphenyl-4-Hydroxy-2',3,3',4',5- Pentachlorobiphenyl"                               99.22 127  99.21  99.21 1.26e-67 
      PDB  2GAB       "Human Transthyretin (Ttr) Complexed With Hydroxylated Polychlorinated Biphenyl-4-Hydroxy-3,3',5,4'- Tetrachlorobiphenyl"                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  2H4E       "Crystal Structure Of Cys10 Sulfonated Transthyretin"                                                                                                      99.22 127  98.43  98.43 2.10e-66 
      PDB  2NOY       "Crystal Structure Of Transthyretin Mutant I84s At Ph 7.5"                                                                                                 99.22 127  98.43  98.43 7.16e-67 
      PDB  2PAB       "Structure Of Prealbumin, Secondary, Tertiary And Quaternary Interactions Determined By Fourier Refinement At 1.8 Angstroms"                               99.22 127  98.43  99.21 1.85e-67 
      PDB  2QGB       "Human Transthyretin (Ttr) In Apo-Form"                                                                                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  2QGC       "Human Transthyretin (Ttr) Complexed With 2-(3,5-Dimethyl-4- Hydroxyphenyl)benzoxazole"                                                                    99.22 127  99.21  99.21 1.26e-67 
      PDB  2QGD       "Human Transthyretin (Ttr) Complexed With 2-(3,5-Dibromo-4- Hydroxyphenyl)benzoxazole"                                                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  2QGE       "Human Transthyretin (Ttr) Complexed With 2-(3,5- Dimethylphenyl)benzoxazole"                                                                              99.22 127  99.21  99.21 1.26e-67 
      PDB  2ROX       "Transthyretin (Also Called Prealbumin) Complex With Thyroxine (T4)"                                                                                       99.22 127  99.21  99.21 1.26e-67 
      PDB  2ROY       "Transthyretin (Also Called Prealbumin) Complex With 3',5'- Dinitro-N-Acetyl-L-Thyronine"                                                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  2TRH       "Tertiary Structures Of Three Amyloidogenic Transthyretin Variants And Implications For Amyloid Fibril Formation"                                          99.22 127  98.43  98.43 2.48e-66 
      PDB  2TRY       "Tertiary Structures Of Three Amyloidogenic Transthyretin Variants And Implications For Amyloid Fibril Formation"                                          99.22 127  98.43  98.43 7.10e-67 
      PDB  3A4D       "Crystal Structure Of Human Transthyretin (Wild-Type)"                                                                                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  3A4E       "Crystal Structure Of Human Transthyretin (E54g)"                                                                                                          99.22 127  98.43  98.43 1.00e-66 
      PDB  3A4F       "Crystal Structure Of Human Transthyretin (E54k)"                                                                                                          99.22 127  98.43  99.21 3.47e-67 
      PDB  3B56       "Crystal Structure Of Transthyretin In Complex With 3,5- Diiodosalicylic Acid"                                                                             99.22 127  99.21  99.21 1.26e-67 
      PDB  3BSZ       "Crystal Structure Of The Transthyretin-Retinol Binding Protein-Fab Complex"                                                                               99.22 127  99.21  99.21 1.26e-67 
      PDB  3BT0       "Crystal Structure Of Transthyretin Variant V20s"                                                                                                          99.22 127  98.43  98.43 5.77e-67 
      PDB  3CBR       "Crystal Structure Of Human Transthyretin (Ttr) At Ph3.5"                                                                                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  3CFM       "Crystal Structure Of The Apo Form Of Human Wild-Type Transthyretin"                                                                                       92.19 118  99.15  99.15 2.42e-62 
      PDB  3CFN       "Crystal Structure Of Human Transthyretin In Complex With 1- Anilino-8-Naphthalene Sulfonate"                                                              92.19 118  99.15  99.15 2.42e-62 
      PDB  3CFQ       "Crystal Structure Of Human Wild-Type Transthyretin In Complex With Diclofenac"                                                                            92.19 118  99.15  99.15 2.42e-62 
      PDB  3CFT       "Crystal Structure Of Human Transthyretin In Complex With 1- Amino-5-Naphthalene Sulfonate"                                                                92.19 118  99.15  99.15 2.42e-62 
      PDB  3CN0       "Human Transthyretin (Ttr) In Complex With 3,5-Dimethyl-4- Hydroxystilbene"                                                                                99.22 127  99.21  99.21 1.26e-67 
      PDB  3CN1       "Human Transthyretin (Ttr) In Complex With 3,5-Dibromo-4- Hydroxystilbene"                                                                                 99.22 127  99.21  99.21 1.26e-67 
      PDB  3CN2       "Human Transthyretin (Ttr) In Complex With 3,5-Dibromo-4- Hydroxybiphenyl"                                                                                 99.22 127  99.21  99.21 1.26e-67 
      PDB  3CN3       "Human Transthyretin (Ttr) In Complex With 1,3-Dibromo-2- Hydroxy-5-Phenoxybenzene"                                                                        99.22 127  99.21  99.21 1.26e-67 
      PDB  3CN4       "Human Transthyretin (Ttr) In Complex With N-(3,5-Dibromo-4- Hydroxyphenyl)benzamide"                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  3CXF       "Crystal Structure Of Transthyretin Variant Y114h"                                                                                                         99.22 127  98.43  99.21 4.72e-67 
      PDB  3D2T       "Human Transthyretin (Ttr) Complexed With Diflunisal"                                                                                                      99.22 127  99.21  99.21 1.26e-67 
      PDB  3D7P       "Crystal Structure Of Human Transthyretin (Ttr) At Ph 4.0"                                                                                                 99.22 127  99.21  99.21 1.26e-67 
      PDB  3DJR       "Crystal Structure Of Transthyretin Variant L58h At Neutral Ph"                                                                                            99.22 127  98.43  98.43 1.23e-66 
      PDB  3DJS       "Crystal Structure Of Transthyretin Variant L58h At Acidic Ph"                                                                                             99.22 127  98.43  98.43 1.23e-66 
      PDB  3DJT       "Crystal Structure Of Transthyretin Variant V30m At Acidic Ph"                                                                                             99.22 127  98.43  99.21 2.55e-67 
      PDB  3DJZ       "Crystal Structure Of Transthyretin Variant L55p At Neutral Ph"                                                                                            99.22 127  98.43  98.43 1.40e-66 
      PDB  3DK0       "Crystal Structure Of Transthyretin Variant L55p At Acidic Ph"                                                                                             99.22 127  98.43  98.43 1.40e-66 
      PDB  3DK2       "Crystal Structure Of Transthyretin Variant Y114h At Acidic Ph"                                                                                            99.22 127  98.43  99.21 4.72e-67 
      PDB  3DO4       "Crystal Structure Of Transthyretin Variant T60a At Acidic Ph"                                                                                             99.22 127  98.43  98.43 4.53e-67 
      PDB  3ESN       "Human Transthyretin (Ttr) Complexed With N-(3,5-Dibromo-4- Hydroxyphenyl)-2,6-Dimethylbenzamide"                                                          99.22 127  99.21  99.21 1.26e-67 
      PDB  3ESO       "Human Transthyretin (Ttr) Complexed With N-(3,5-Dibromo-4- Hydroxyphenyl)-2,5-Dichlorobenzamide"                                                          99.22 127  99.21  99.21 1.26e-67 
      PDB  3ESP       "Human Transthyretin (Ttr) Complexed With N-(3,5-Dibromo-4- Hydroxyphenyl)-3,5-Dimethyl-4-Hydroxybenzamide"                                                99.22 127  99.21  99.21 1.26e-67 
      PDB  3FC8       "Crystal Structure Of Transthyretin In Complex With Iododiflunisal-Betaalaome"                                                                             96.88 124  99.19  99.19 8.54e-66 
      PDB  3FCB       "Crystal Structure Of Transthyretin In Complex With Iododiflunisal-Betaalaoh"                                                                              96.88 124  99.19  99.19 8.54e-66 
      PDB  3GLZ       "Human Transthyretin (Ttr) Complexed With(E)-3-(2- (Trifluoromethyl)benzylideneaminooxy)propanoic Acid (Inhibitor 11)"                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  3GS0       "Human Transthyretin (Ttr) Complexed With (S)-3-(9h-Fluoren- 9-Ylideneaminooxy)-2-Methylpropanoic Acid (Inhibitor 16)"                                     99.22 127  99.21  99.21 1.26e-67 
      PDB  3GS4       "Human Transthyretin (Ttr) Complexed With 3-(9h-Fluoren-9- Ylideneaminooxy)propanoic Acid (Inhibitor 15)"                                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  3GS7       "Human Transthyretin (Ttr) Complexed With (E)-3-(2- Methoxybenzylideneaminooxy)propanoic Acid (Inhibitor 13)"                                              99.22 127  99.21  99.21 1.26e-67 
      PDB  3HJ0       "Transthyretin In Complex With A Covalent Small Molecule Kinetic Stabilizer"                                                                               99.22 127  98.43  98.43 2.10e-66 
      PDB  3I9P       "Crystal Structure Of Human Transthyretin - Wild Type"                                                                                                     90.63 116  99.14  99.14 3.53e-61 
      PDB  3IMR       "Transthyretin In Complex With (E)-2,6-Dibromo-4-(2,6- Dichlorostyryl)phenol"                                                                              99.22 127  99.21  99.21 1.26e-67 
      PDB  3IMS       "Transthyretin In Complex With 2,6-Dibromo-4-(2,6- Dichlorophenethyl)phenol"                                                                               99.22 127  99.21  99.21 1.26e-67 
      PDB  3IMT       "Transthyretin In Complex With (E)-4-(4-Aminostyryl)-2,6- Dibromophenol"                                                                                   99.22 127  99.21  99.21 1.26e-67 
      PDB  3IMU       "Transthyretin In Complex With (E)-4-(3-Aminostyryl)-2,6- Dibromoaniline"                                                                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  3IMV       "Transthyretin In Complex With (E)-4-(4-Aminostyryl)-2,6- Dibromoaniline"                                                                                  99.22 127  99.21  99.21 1.26e-67 
      PDB  3IMW       "Transthyretin In Complex With (E)-2,6-Dibromo-4-(2,6- Dimethoxystyryl)aniline"                                                                            99.22 127  99.21  99.21 1.26e-67 
      PDB  3KGS       "V30m Mutant Human Transthyretin (Ttr) (Apov30m) Ph 7.5"                                                                                                   99.22 127  98.43  99.21 2.55e-67 
      PDB  3KGT       "V30m Mutant Human Transthyretin (Ttr) Complexed With Genistein (V30m:gen) Ph 7.5"                                                                         99.22 127  98.43  99.21 2.55e-67 
      PDB  3KGU       "Wild Type Human Transthyretin (Ttr) Complexed With Genistein (Ttrwt:gen) Ph 7.5"                                                                          99.22 127  99.21  99.21 1.26e-67 
      PDB  5TTR       "Leu 55 Pro Transthyretin Crystal Structure"                                                                                                               99.22 127  98.43  98.43 1.40e-66 
      DBJ  BAA00059   "prealbumin [Homo sapiens]"                                                                                                                                99.22 147  98.43  99.21 1.46e-67 
      DBJ  BAG34987   "unnamed protein product [Homo sapiens]"                                                                                                                   99.22 147  99.21  99.21 6.75e-68 
      EMBL CAA42087   "transthyretin [Homo sapiens]"                                                                                                                             99.22 147  99.21  99.21 6.75e-68 
      EMBL CAG33189   "TTR [Homo sapiens]"                                                                                                                                       99.22 147  98.43  99.21 1.46e-67 
      GB   AAA60011   "prealbumin [Homo sapiens]"                                                                                                                                99.22 147  99.21  99.21 6.75e-68 
      GB   AAA60012   "prealbumin [Homo sapiens]"                                                                                                                                99.22 147  99.21  99.21 6.75e-68 
      GB   AAA60013   "prealbumin precursor [Homo sapiens]"                                                                                                                      99.22 147  99.21  99.21 6.75e-68 
      GB   AAA60018   "prealbumin [Homo sapiens]"                                                                                                                                99.22 147  98.43  99.21 1.46e-67 
      GB   AAA61181   "transthyretin [Homo sapiens]"                                                                                                                             91.41 117  99.15  99.15 3.77e-61 
      PRF  0908191A   "prealbumin,thyroxine binding"                                                                                                                             99.22 127  99.21  99.21 1.26e-67 
      PRF  1101213A   "protein,amyloid fibril"                                                                                                                                   99.22 127  99.21  99.21 1.26e-67 
      PRF  1709210A    transthyretin                                                                                                                                             99.22 147  99.21  99.21 6.75e-68 
      REF  NP_000362  "transthyretin precursor [Homo sapiens]"                                                                                                                   99.22 147  99.21  99.21 6.75e-68 
      SP   P02766     "RecName: Full=Transthyretin; AltName: Full=Prealbumin; AltName: Full=TBPA; AltName: Full=TTR; AltName: Full=ATTR; Flags: Precursor"                       99.22 147  99.21  99.21 6.75e-68 

   stop_

save_


    ####################
    #  Natural source  #
    ####################

save_natural_source
   _Saveframe_category   natural_source


   loop_
      _Mol_label
      _Organism_name_common
      _NCBI_taxonomy_ID
      _Superkingdom
      _Kingdom
      _Genus
      _Species

      $TTR_T119M Human 9606 Eukaryota Metazoa Homo sapiens 

   stop_

save_


    #########################
    #  Experimental source  #
    #########################

save_experimental_source
   _Saveframe_category   experimental_source


   loop_
      _Mol_label
      _Production_method
      _Host_organism_name_common
      _Genus
      _Species
      _Strain
      _Vector_name

      $TTR_T119M 'recombinant technology' . . . . . 

   stop_

save_


#####################################
#  Sample contents and methodology  #
#####################################
	 
    ########################
    #  Sample description  #
    ########################

save_sample_1
   _Saveframe_category   sample

   _Sample_type          solution

   loop_
      _Mol_label
      _Concentration_value
      _Concentration_value_units
      _Concentration_min_value
      _Concentration_max_value
      _Isotopic_labeling

      $TTR_T119M    . mM 0.3 1.5 "[U-C13; U-N15]" 
       D2O       100 %   .   .   .               

   stop_

save_


#########################
#  Experimental detail  #
#########################

    ##################################
    #  NMR Spectrometer definitions  #
    ##################################

save_NMR_spectrometer
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Bruker
   _Model                DRX
   _Field_strength       600

save_


    #############################
    #  NMR applied experiments  #
    #############################

save_NMR_applied_experiment
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name     
;
HSQC 
HNCA 
HNCACB 
1H-15N NOESY
;

save_


#######################
#  Sample conditions  #
#######################

save_sample_cond_1
   _Saveframe_category   sample_conditions


   loop_
      _Variable_type
      _Variable_value
      _Variable_value_error
      _Variable_value_units

      pH            7.0 0.1 n/a 
      temperature 298   2   K   

   stop_

save_


####################
#  NMR parameters  #
####################

    ##############################
    #  Assigned chemical shifts  #
    ##############################

	################################
	#  Chemical shift referencing  #
	################################

save_chemical_shift_reference
   _Saveframe_category   chemical_shift_reference


   loop_
      _Mol_common_name
      _Atom_type
      _Atom_isotope_number
      _Atom_group
      _Chem_shift_units
      _Chem_shift_value
      _Reference_method
      _Reference_type
      _External_reference_sample_geometry
      _External_reference_location
      _External_reference_axis
      _Indirect_shift_ratio

      DSS N 15 'methyl protons' ppm 0.0 .        indirect . . . 0.101329118 
      DSS C 13 'methyl protons' ppm 0.0 .        indirect . . . 0.251449530 
      DSS H  1 'methyl protons' ppm 0.0 internal direct   . . . 1.0         

   stop_

save_


	###################################
	#  Assigned chemical shift lists  #
	###################################

###################################################################
#       Chemical Shift Ambiguity Index Value Definitions          #
#                                                                 #
# The values other than 1 are used for those atoms with different #
# chemical shifts that cannot be assigned to stereospecific atoms #
# or to specific residues or chains.                              #
#                                                                 #
#   Index Value            Definition                             #
#                                                                 #
#      1             Unique (including isolated methyl protons,   #
#                         geminal atoms, and geminal methyl       #
#                         groups with identical chemical shifts)  #
#                         (e.g. ILE HD11, HD12, HD13 protons)     #
#      2             Ambiguity of geminal atoms or geminal methyl #
#                         proton groups (e.g. ASP HB2 and HB3     #
#                         protons, LEU CD1 and CD2 carbons, or    #
#                         LEU HD11, HD12, HD13 and HD21, HD22,    #
#                         HD23 methyl protons)                    #
#      3             Aromatic atoms on opposite sides of          #
#                         symmetrical rings (e.g. TYR HE1 and HE2 #
#                         protons)                                #
#      4             Intraresidue ambiguities (e.g. LYS HG and    #
#                         HD protons or TRP HZ2 and HZ3 protons)  #
#      5             Interresidue ambiguities (LYS 12 vs. LYS 27) #
#      6             Intermolecular ambiguities (e.g. ASP 31 CA   #
#                         in monomer 1 and ASP 31 CA in monomer 2 #
#                         of an asymmetrical homodimer, duplex    #
#                         DNA assignments, or other assignments   #
#                         that may apply to atoms in one or more  #
#                         molecule in the molecular assembly)     #
#      9             Ambiguous, specific ambiguity not defined    #
#                                                                 #
###################################################################

save_cs
   _Saveframe_category               assigned_chemical_shifts


   loop_
      _Sample_label

      $sample_1 

   stop_

   _Sample_conditions_label         $sample_cond_1
   _Chem_shift_reference_set_label  $chemical_shift_reference
   _Mol_system_component_name       "TTR subunit 1"

   loop_
      _Atom_shift_assign_ID
      _Residue_PDB_seq_code
      _Residue_seq_code
      _Residue_label
      _Atom_name
      _Atom_type
      _Chem_shift_value
      _Chem_shift_value_error
      _Chem_shift_ambiguity_code

         1    0    1 MET CA    C  53.890 0.10 1
         2    1    2 GLY N     N 108.780 0.25 1
         3    1    2 GLY H     H   8.430 0.05 1
         4    1    2 GLY CA    C  46.460 0.10 1
         5    2    3 PRO CA    C  63.410 0.10 1
         6    3    4 THR N     N 113.440 0.04 1
         7    3    4 THR H     H   8.150 0.01 1
         8    3    4 THR CA    C  61.890 0.10 1
         9    4    5 GLY N     N 110.890 0.02 1
        10    4    5 GLY H     H   8.280 0.01 1
        11    4    5 GLY CA    C  45.450 0.10 1
        12    5    6 THR N     N 112.930 0.07 1
        13    5    6 THR H     H   8.030 0.00 1
        14    5    6 THR CA    C  61.840 0.10 1
        15    6    7 GLY N     N 110.960 0.03 1
        16    6    7 GLY H     H   8.350 0.00 1
        17    6    7 GLY CA    C  45.460 0.10 1
        18    7    8 GLU N     N 120.500 0.03 1
        19    7    8 GLU H     H   8.150 0.00 1
        20    7    8 GLU CA    C  56.440 0.10 1
        21    8    9 SER N     N 116.730 0.07 1
        22    8    9 SER H     H   8.250 0.01 1
        23    8    9 SER CA    C  58.400 0.10 1
        24    9   10 LYS N     N 122.630 0.13 1
        25    9   10 LYS H     H   8.300 0.00 1
        26    9   10 LYS CA    C  55.710 0.10 1
        27   10   11 CYS N     N 119.680 0.00 1
        28   10   11 CYS H     H   8.200 0.00 1
        30   11   12 PRO CA    C  64.640 0.10 1
        31   12   13 LEU N     N 115.770 0.07 1
        32   12   13 LEU H     H   6.800 0.00 1
        33   12   13 LEU CA    C  53.830 0.10 1
        34   13   14 MET N     N 126.940 0.04 1
        35   13   14 MET H     H   8.600 0.01 1
        36   13   14 MET CA    C  54.850 0.10 1
        37   14   15 VAL N     N 122.000 0.21 1
        38   14   15 VAL H     H   7.500 0.05 1
        39   14   15 VAL CA    C  59.640 0.10 1
        40   15   16 LYS N     N 127.630 0.08 1
        41   15   16 LYS H     H   8.850 0.00 1
        42   15   16 LYS CA    C  54.580 0.10 1
        43   16   17 VAL N     N 124.580 0.07 1
        44   16   17 VAL H     H   9.100 0.00 1
        45   16   17 VAL CA    C  60.770 0.01 1
        46   17   18 LEU N     N 126.120 0.01 1
        47   17   18 LEU H     H   8.620 0.01 1
        48   17   18 LEU CA    C  53.770 0.10 1
        49   18   19 ASP N     N 121.730 0.02 1
        50   18   19 ASP H     H   8.770 0.00 1
        51   18   19 ASP CA    C  53.380 0.10 1
        52   19   20 ALA N     N 127.130 0.08 1
        53   19   20 ALA H     H   9.110 0.01 1
        54   19   20 ALA CA    C  53.770 0.10 1
        55   20   21 VAL N     N 120.770 0.00 1
        56   20   21 VAL H     H   9.730 0.01 1
        57   20   21 VAL CA    C  65.460 0.10 1
        58   21   22 ARG N     N 116.700 0.01 1
        59   21   22 ARG H     H   8.230 0.00 1
        60   21   22 ARG CA    C  55.570 0.10 1
        61   22   23 GLY N     N 109.890 0.02 1
        62   22   23 GLY H     H   7.600 0.00 1
        63   22   23 GLY CA    C  47.420 0.10 1
        64   23   24 SER N     N 111.450 0.07 1
        65   23   24 SER H     H   7.460 0.00 1
        66   23   24 SER CA    C  55.340 0.10 1
        67   24   25 PRO CA    C  62.770 0.10 1
        68   25   26 ALA N     N 127.250 0.10 1
        69   25   26 ALA H     H   8.230 0.00 1
        70   25   26 ALA CA    C  50.710 0.10 1
        71   26   27 ILE N     N 127.020 0.07 1
        72   26   27 ILE H     H   7.850 0.00 1
        73   26   27 ILE CA    C  61.850 0.10 1
        74   27   28 ASN N     N 122.310 0.03 1
        75   27   28 ASN H     H   7.800 0.00 1
        76   27   28 ASN CA    C  54.380 0.10 1
        77   28   29 VAL N     N 119.810 0.09 1
        78   28   29 VAL H     H   8.350 0.00 1
        79   28   29 VAL CA    C  61.620 0.10 1
        80   29   30 ALA N     N 130.710 0.08 1
        81   29   30 ALA H     H   9.130 0.00 1
        82   29   30 ALA CA    C  52.810 0.10 1
        83   30   31 VAL N     N 122.130 0.14 1
        84   30   31 VAL H     H   8.450 0.00 1
        85   30   31 VAL CA    C  60.450 0.10 1
        86   31   32 HIS N     N 123.730 0.08 1
        87   31   32 HIS H     H   9.030 0.00 1
        88   31   32 HIS CA    C  54.910 0.10 1
        89   32   33 VAL N     N 122.230 0.04 1
        90   32   33 VAL H     H   9.230 0.00 1
        91   32   33 VAL CA    C  60.140 0.10 1
        92   33   34 PHE N     N 128.270 0.11 1
        93   33   34 PHE H     H   9.900 0.00 1
        94   33   34 PHE CA    C  56.140 0.10 1
        95   34   35 ARG N     N 122.450 0.11 1
        96   34   35 ARG H     H   9.530 0.01 1
        97   34   35 ARG CA    C  54.210 0.10 1
        98   35   36 LYS N     N 129.970 0.13 1
        99   35   36 LYS H     H   8.610 0.00 1
       100   35   36 LYS CA    C  57.120 0.10 1
       101   36   37 ALA N     N 131.310 0.05 1
       102   36   37 ALA H     H   8.780 0.00 1
       103   36   37 ALA CA    C  51.030 0.10 1
       104   37   38 ALA N     N 122.050 0.02 1
       105   37   38 ALA H     H   8.310 0.01 1
       106   37   38 ALA CA    C  53.930 0.10 1
       107   38   39 ASP N     N 115.770 0.06 1
       108   38   39 ASP H     H   7.760 0.01 1
       109   38   39 ASP CA    C  53.470 0.10 1
       110   39   40 ASP N     N 113.390 0.02 1
       111   39   40 ASP H     H   7.940 0.01 1
       112   39   40 ASP CA    C  55.940 0.10 1
       113   40   41 THR N     N 110.950 0.04 1
       114   40   41 THR H     H   7.290 0.00 1
       115   40   41 THR CA    C  61.400 0.10 1
       116   41   42 TRP N     N 120.490 0.02 1
       117   41   42 TRP H     H   8.380 0.00 1
       118   41   42 TRP CA    C  55.550 0.10 1
       119   41   42 TRP NE1   N 129.010 0.10 1
       120   41   42 TRP HE1   H   9.890 0.01 1
       121   42   43 GLU N     N 126.190 0.06 1
       122   42   43 GLU H     H   9.310 0.00 1
       123   42   43 GLU CA    C  53.130 0.10 1
       124   43   44 PRO CA    C  64.530 0.10 1
       125   44   45 PHE N     N 125.010 0.05 1
       126   44   45 PHE H     H   8.830 0.00 1
       127   44   45 PHE CA    C  59.100 0.10 1
       128   45   46 ALA N     N 118.530 0.07 1
       129   45   46 ALA H     H   7.920 0.00 1
       130   45   46 ALA CA    C  52.270 0.10 1
       131   46   47 SER N     N 113.280 0.01 1
       132   46   47 SER H     H   8.530 0.01 1
       133   46   47 SER CA    C  57.670 0.10 1
       134   47   48 GLY N     N 106.170 0.00 1
       135   47   48 GLY H     H   8.370 0.00 1
       136   47   48 GLY CA    C  45.810 0.10 1
       137   48   49 LYS N     N 120.010 0.04 1
       138   48   49 LYS H     H   8.440 0.00 1
       139   48   49 LYS CA    C  53.880 0.10 1
       140   49   50 THR N     N 111.510 0.05 1
       141   49   50 THR H     H   8.650 0.01 1
       142   49   50 THR CA    C  62.120 0.10 1
       143   50   51 SER N     N 118.150 0.03 1
       144   50   51 SER H     H   8.510 0.00 1
       145   50   51 SER CA    C  57.170 0.10 1
       146   51   52 GLU N     N 118.630 0.08 1
       147   51   52 GLU H     H   9.050 0.00 1
       148   51   52 GLU CA    C  59.150 0.10 1
       149   52   53 SER N     N 111.500 0.04 1
       150   52   53 SER H     H   8.080 0.00 1
       151   52   53 SER CA    C  57.530 0.10 1
       152   53   54 GLY N     N 111.900 0.03 1
       153   53   54 GLY H     H   8.570 0.00 1
       154   53   54 GLY CA    C  45.570 0.10 1
       155   54   55 GLU N     N 115.300 0.03 1
       156   54   55 GLU H     H   7.240 0.00 1
       157   54   55 GLU CA    C  54.390 0.10 1
       158   55   56 LEU N     N 123.790 0.03 1
       159   55   56 LEU H     H   8.740 0.00 1
       160   55   56 LEU CA    C  53.990 0.10 1
       161   56   57 HIS N     N 124.300 0.04 1
       162   56   57 HIS H     H   8.680 0.01 1
       163   56   57 HIS CA    C  54.260 0.10 1
       164   57   58 GLY N     N 109.030 0.10 1
       165   57   58 GLY H     H   9.090 0.01 1
       166   57   58 GLY CA    C  46.610 0.10 1
       167   58   59 LEU N     N 119.580 0.08 1
       168   58   59 LEU H     H   8.120 0.01 1
       169   58   59 LEU CA    C  57.030 0.00 1
       170   59   60 THR N     N 109.510 0.17 1
       171   59   60 THR H     H   7.840 0.08 1
       172   59   60 THR CA    C  59.210 0.10 1
       173   60   61 THR N     N 111.270 0.01 1
       174   60   61 THR H     H   8.380 0.01 1
       175   60   61 THR CA    C  59.610 0.10 1
       176   61   62 GLU N     N 121.400 0.04 1
       177   61   62 GLU H     H   9.240 0.00 1
       178   61   62 GLU CA    C  60.060 0.10 1
       179   62   63 GLU N     N 115.980 0.00 1
       180   62   63 GLU H     H   8.650 0.00 1
       181   62   63 GLU CA    C  59.000 0.10 1
       182   63   64 GLU N     N 115.360 0.02 1
       183   63   64 GLU H     H   7.230 0.00 1
       184   63   64 GLU CA    C  56.800 0.10 1
       185   64   65 PHE N     N 123.800 0.04 1
       186   64   65 PHE H     H   7.830 0.02 1
       187   64   65 PHE CA    C  54.300 0.10 1
       188   65   66 VAL N     N 115.220 0.01 1
       189   65   66 VAL H     H   7.180 0.01 1
       190   65   66 VAL CA    C  60.210 0.10 1
       191   66   67 GLU N     N 121.870 0.03 1
       192   66   67 GLU H     H   8.560 0.00 1
       193   66   67 GLU CA    C  56.840 0.10 1
       194   67   68 GLY N     N 111.050 0.04 1
       195   67   68 GLY H     H   7.920 0.01 1
       196   67   68 GLY CA    C  44.680 0.10 1
       197   68   69 ILE N     N 120.660 0.10 1
       198   68   69 ILE H     H   8.330 0.00 1
       199   68   69 ILE CA    C  60.780 0.10 1
       200   69   70 TYR N     N 124.790 0.10 1
       201   69   70 TYR H     H   8.680 0.00 1
       202   69   70 TYR CA    C  56.360 0.10 1
       203   70   71 LYS N     N 118.630 0.01 1
       204   70   71 LYS H     H   8.720 0.00 1
       205   70   71 LYS CA    C  53.720 0.10 1
       206   71   72 VAL N     N 127.410 0.09 1
       207   71   72 VAL H     H   9.630 0.01 1
       208   71   72 VAL CA    C  61.170 0.10 1
       209   72   73 GLU N     N 128.240 0.07 1
       210   72   73 GLU H     H   9.660 0.01 1
       211   72   73 GLU CA    C  55.240 0.10 1
       212   73   74 ILE N     N 126.150 0.04 1
       213   73   74 ILE H     H   9.180 0.00 1
       214   73   74 ILE CA    C  60.290 0.10 1
       215   74   75 ASP N     N 128.510 0.04 1
       216   74   75 ASP H     H   8.950 0.10 1
       217   74   75 ASP CA    C  53.720 0.10 1
       218   75   76 THR N     N 117.220 0.01 1
       219   75   76 THR H     H   8.230 0.00 1
       220   75   76 THR CA    C  64.450 0.10 1
       221   76   77 LYS N     N 124.560 0.10 1
       222   76   77 LYS H     H   7.520 0.00 1
       223   76   77 LYS CA    C  60.330 0.10 1
       224   77   78 SER N     N 112.950 0.07 1
       225   77   78 SER H     H   8.180 0.00 1
       226   77   78 SER CA    C  61.780 0.10 1
       227   78   79 TYR N     N 121.210 0.01 1
       228   78   79 TYR H     H   6.790 0.00 1
       229   78   79 TYR CA    C  61.180 0.10 1
       230   79   80 TRP N     N 117.240 0.09 1
       231   79   80 TRP H     H   7.880 0.00 1
       232   79   80 TRP CA    C  59.210 0.10 1
       233   79   80 TRP NE1   N 126.520 0.10 1
       234   79   80 TRP HE1   H  10.240 0.01 1
       235   80   81 LYS N     N 118.190 0.04 1
       236   80   81 LYS H     H   8.710 0.00 1
       237   80   81 LYS CA    C  59.780 0.10 1
       238   81   82 ALA N     N 122.180 0.10 1
       239   81   82 ALA H     H   7.530 0.00 1
       240   81   82 ALA CA    C  54.370 0.10 1
       241   82   83 LEU N     N 117.580 0.10 1
       242   82   83 LEU H     H   7.310 0.01 1
       243   82   83 LEU CA    C  54.530 0.10 1
       244   83   84 GLY N     N 107.470 0.01 1
       245   83   84 GLY H     H   7.960 0.00 1
       246   83   84 GLY CA    C  45.630 0.10 1
       247   84   85 ILE N     N 122.860 0.05 1
       248   84   85 ILE H     H   7.920 0.00 1
       249   84   85 ILE CA    C  59.720 0.10 1
       250   85   86 SER N     N 121.880 0.01 1
       251   85   86 SER H     H   8.410 0.00 1
       252   85   86 SER CA    C  54.910 0.10 1
       253   86   87 PRO CA    C  61.320 0.10 1
       254   87   88 PHE N     N 116.000 0.04 1
       255   87   88 PHE H     H   7.370 0.00 1
       256   87   88 PHE CA    C  60.230 0.10 1
       257   88   89 HIS N     N 113.010 0.12 1
       258   88   89 HIS H     H   7.670 0.00 1
       259   88   89 HIS CA    C  58.080 0.10 1
       260   89   90 GLU N     N 122.620 0.10 1
       261   89   90 GLU H     H   8.360 0.00 1
       262   89   90 GLU CA    C  53.380 0.10 1
       263   90   91 HIS N     N 116.740 0.06 1
       264   90   91 HIS H     H   8.100 0.00 1
       265   90   91 HIS CA    C  54.600 0.10 1
       266   91   92 ALA N     N 120.060 0.12 1
       267   91   92 ALA H     H   8.510 0.00 1
       268   91   92 ALA CA    C  51.770 0.10 1
       269   92   93 GLU N     N 120.730 0.08 1
       270   92   93 GLU H     H   8.160 0.00 1
       271   92   93 GLU CA    C  54.590 0.10 1
       272   93   94 VAL N     N 121.820 0.08 1
       273   93   94 VAL H     H   8.870 0.00 1
       274   93   94 VAL CA    C  61.410 0.10 1
       275   94   95 VAL N     N 128.000 0.06 1
       276   94   95 VAL H     H   9.300 0.00 1
       277   94   95 VAL CA    C  61.090 0.10 1
       278   95   96 PHE N     N 124.740 0.05 1
       279   95   96 PHE H     H   9.050 0.01 1
       280   95   96 PHE CA    C  56.110 0.10 1
       281   96   97 THR N     N 118.360 0.05 1
       282   96   97 THR H     H   8.570 0.01 1
       283   96   97 THR CA    C  62.900 0.10 1
       284   97   98 ALA N     N 129.430 0.08 1
       285   97   98 ALA H     H   9.160 0.00 1
       286   97   98 ALA CA    C  50.030 0.10 1
       287   98   99 ASN N     N 112.030 0.08 1
       288   98   99 ASN H     H   8.590 0.00 1
       289   98   99 ASN CA    C  54.550 0.10 1
       290   99  100 ASP N     N 117.190 0.03 1
       291   99  100 ASP H     H   8.880 0.00 1
       292   99  100 ASP CA    C  55.720 0.10 1
       293  100  101 SER N     N 117.180 0.00 1
       294  100  101 SER H     H   8.780 0.01 1
       295  100  101 SER CA    C  57.250 0.10 1
       296  101  102 GLY N     N 110.070 0.00 1
       297  101  102 GLY H     H   7.190 0.01 1
       298  101  102 GLY CA    C  43.790 0.10 1
       299  102  103 PRO CA    C  57.890 0.10 1
       300  103  104 ARG N     N 121.330 0.04 1
       301  103  104 ARG H     H   8.910 0.01 1
       302  103  104 ARG CA    C  58.140 0.10 1
       303  104  105 ARG N     N 106.080 0.01 1
       304  104  105 ARG H     H   7.270 0.00 1
       305  104  105 ARG CA    C  54.600 0.10 1
       306  105  106 TYR N     N 121.280 0.08 1
       307  105  106 TYR H     H   8.860 0.00 1
       308  105  106 TYR CA    C  58.000 0.10 1
       309  106  107 THR N     N 120.790 0.16 1
       310  106  107 THR H     H   8.900 0.00 1
       311  106  107 THR CA    C  61.870 0.10 1
       312  107  108 ILE N     N 127.110 0.06 1
       313  107  108 ILE H     H   8.800 0.01 1
       314  107  108 ILE CA    C  58.550 0.01 1
       315  108  109 ALA N     N 127.840 0.05 1
       316  108  109 ALA H     H   8.750 0.00 1
       317  108  109 ALA CA    C  49.210 0.10 1
       318  109  110 ALA N     N 124.100 0.04 1
       319  109  110 ALA H     H   8.890 0.00 1
       320  109  110 ALA CA    C  50.650 0.10 1
       321  110  111 LEU N     N 124.090 0.02 1
       322  110  111 LEU H     H   8.930 0.01 1
       323  110  111 LEU CA    C  54.040 0.10 1
       324  111  112 LEU N     N 123.230 0.07 1
       325  111  112 LEU H     H   9.180 0.01 1
       326  111  112 LEU CA    C  55.710 0.10 1
       327  112  113 SER N     N 116.730 0.01 1
       328  112  113 SER H     H   8.990 0.01 1
       329  112  113 SER CA    C  58.140 0.10 1
       330  113  114 PRO CA    C  61.800 0.10 1
       331  114  115 TYR N     N 113.440 0.00 1
       332  114  115 TYR H     H   8.370 0.01 1
       333  114  115 TYR CA    C  58.350 0.10 1
       334  115  116 SER N     N 112.100 0.01 1
       335  115  116 SER H     H   7.560 0.01 1
       336  115  116 SER CA    C  57.150 0.10 1
       337  116  117 TYR N     N 120.350 0.32 1
       338  116  117 TYR H     H   8.330 0.02 1
       339  116  117 TYR CA    C  55.220 0.10 1
       340  117  118 SER N     N 114.830 0.00 1
       341  117  118 SER H     H   8.470 0.01 1
       342  117  118 SER CA    C  56.580 0.00 1
       343  118  119 THR N     N 115.850 0.03 1
       344  118  119 THR H     H   8.950 0.01 1
       345  118  119 THR CA    C  58.280 0.00 1
       346  119  120 MET N     N 122.140 0.06 1
       347  119  120 MET H     H   8.290 0.01 1
       348  119  120 MET CA    C  53.890 0.05 1
       349  120  121 ALA N     N 128.250 0.04 1
       350  120  121 ALA H     H   8.230 0.01 1
       351  120  121 ALA CA    C  50.200 0.10 1
       352  121  122 VAL N     N 118.980 0.24 1
       353  121  122 VAL H     H   8.320 0.00 1
       354  121  122 VAL CA    C  60.320 0.10 1
       355  122  123 VAL N     N 128.440 0.04 1
       356  122  123 VAL H     H   8.270 0.00 1
       357  122  123 VAL CA    C  60.880 0.10 1
       358  123  124 THR N     N 119.990 0.03 1
       359  123  124 THR H     H   8.730 0.00 1
       360  123  124 THR CA    C  60.350 0.10 1
       361  124  125 ASN N     N 121.790 0.03 1
       362  124  125 ASN H     H   8.680 0.00 1
       363  124  125 ASN CA    C  50.650 0.10 1
       364  125  126 PRO CA    C  63.410 0.10 1
       365  126  127 LYS N     N 120.400 0.04 1
       366  126  127 LYS H     H   8.020 0.00 1
       367  126  127 LYS CA    C  56.090 0.10 1
       368  127  128 GLU N     N 126.640 0.02 1
       369  127  128 GLU H     H   7.670 0.01 1
       370  127  128 GLU CA    C  58.010 0.10 1

   stop_

save_

